FreeCME

Bench to Bedside: Transforming the Diagnosis and Treatment of CLL

CME: 0.75

Hematology/Oncology, Oncology Bench to Bedside: Transforming the Diagnosis and Treatment of CLL

Dramatic progress has been made in our understanding of the clinical, biological and molecular heterogeneity of chronic lymphocytic leukemia (CLL). Despite this, treatment challenges remain, particularly in patients with high-risk disease. These activities featuring Dr. John N. Allan addresses the question of how to integrate the latest knowledge into clinical practice to help guide treatment choices for patients with high-risk CLL.

Post a comment to this article